RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA
Clinical trial NCT01497808 · COMPLETED
Trial details
- NCT number
- NCT01497808
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-29
- Primary completion
- 2013-12-29
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.